Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Parallel, Placebo-controlled, Randomised Clinical Trial to Evaluate the Efficacy of Turmipure Gold® to Improve Cognitive Performance in Healthy Aging.

NCT04860050 is registered in ClinicalTrials.gov with Givaudan France Naturals as lead sponsor.

NCT NCT04860050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04860050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Parallel, Placebo-controlled, Randomised Clinical Trial to Evaluate the Efficacy of Turmipure Gold® to Improve Cognitive Performance in Healthy Aging.
Lead sponsor
Givaudan France Naturals
Phase
Not applicable
Overall status
Completed
Start date
April 19, 2021
Completion date
August 10, 2023
Enrollment
568 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive change, mood, stress